血液透析患者红细胞生成素反应性影响因素的相关分析
俞卫红， 熊浩， 宋杰， 袁芳 - 中国血液净化, 2022 - cjbp.org.cn
… -6,IL-6),每周使用红细胞生成刺激剂(erythropoiesis-stimulating agents,ESAs)剂 量更低(Z 值
分别为-2.738,-8.820,P… Associations between changes in hemoglobin and administered eryth- …
分别为-2.738,-8.820,P… Associations between changes in hemoglobin and administered eryth- …
[PDF][PDF] 持续性红细胞生成素受体激活剂静脉给药在慢性肾脏病透析患者中纠正贫血的疗效, 安全性和耐受性
钱家麒， 陈楠， 梅长林， 刘文虎， 侯凡凡， 史伟， 陈江华… - 2012 - cjn.org.cn
… chronic renal anemia who had not been treated with erythropoiesis⁃stimulating agents (… to
receive either CERA once every 2 weeks intravenous administration (CERA group, n=132) or …
receive either CERA once every 2 weeks intravenous administration (CERA group, n=132) or …
DOPPS 研究引发的思考-血红蛋白波动与透析患者死亡正相关
陈雅， 倪兆慧 - 中国血液净化, 2012 - cjbp.org.cn
… [Abstract]With the progresses of renal anemia administration, … factors, the relationship
between hemoglobin fluctuation and … patients receiving erythropoiesis stimulating agents for the …
between hemoglobin fluctuation and … patients receiving erythropoiesis stimulating agents for the …
[PDF][PDF] 中国髋, 膝关节置换术加速康复——围术期贫血诊治专家共识
周宗科， 翁习生， 向兵， 曲铁兵， 张先龙… - Chinese Journal of …, 2016 - medibone.cn
… The relationship between admission hemoglobin level and … Changes of hemoglobin and
hematocrit in elderly patients … Usefulness of the administration of intravenous iron sucrose …
hematocrit in elderly patients … Usefulness of the administration of intravenous iron sucrose …
[PDF][PDF] 低葡萄糖降解产物腹膜透析液的研究进展
李卫卫， 刘虹， 刘伏友 - 中国血液净化, 2012 - cjbp.org.cn
… [Abstract]With the progresses of renal anemia administration, … factors, the relationship
between hemoglobin fluctuation and … patients receiving erythropoiesis stimulating agents for the …
between hemoglobin fluctuation and … patients receiving erythropoiesis stimulating agents for the …
[PDF][PDF] 老年骨髓增生异常综合征的临床病理特征及氨磷汀联合造血生长因子方案的长期疗效观察
于睿莉， 杨波， 蔡力力， 迟小华… - 中国药物应用 …, 2017 - pro5c129b.pic19.websiteonline.cn
… of hematopoietic growth factor alone, administration of … Tab 4 The relationship of survival
time with hemoglobin level… Efficacy and safety of erythropoiesis-stimulating Proteins in …
time with hemoglobin level… Efficacy and safety of erythropoiesis-stimulating Proteins in …
肾性贫血的药物治疗现状与进展
喻倩， 路香雪， 张嘉铃， 李寒， 王世相 - 中国血液净化, 2020 - cjbp.org.cn
… times- per- week administration of erythropoiesis stimulating agents in united states dialysis
… CERA Administered once monthly corrects and maintains stable hemoglobin levels in …
… CERA Administered once monthly corrects and maintains stable hemoglobin levels in …
促红细胞生成素治疗创伤性脑损伤的机制: 转录组学和生物信息学分析
W Tan, J Ma, J Fu, B Wu, Z Zhu, X Huang… - 中国神经再生研究 …, 2024 - sjzsyj.com.cn
… showed that regulatory relationship between the differentially … There are clear monthly changes
in estrogen and … (2010) Erythropoiesis stimulating agent administration improves survival …
in estrogen and … (2010) Erythropoiesis stimulating agent administration improves survival …
[PDF][PDF] 促红细胞生成素的早产儿临床应用研究进展
傅晓燕， 谢晓恬 - 世界临床药物, 2020 - jwph.com.cn
… ,多年来被应 用于早产儿贫血(anemia of prematurity,AOP) 的防 治,其… Update on
erythropoiesis-stimulating agents administered to … Association between early administration of …
erythropoiesis-stimulating agents administered to … Association between early administration of …
[PDF][PDF] 铁剂在慢性肾脏病贫血患者中应用的临床实践指南
左力 - 中国血液净化, 2022 - cjbp.org.cn
… Erythropoiesis-stimulating agents … Food and Drug Administration … Time-dependent
associations between iron and mortality in hemodialysis patients[J]. J Am Soc Nephrol, 2005, 16(10): …
associations between iron and mortality in hemodialysis patients[J]. J Am Soc Nephrol, 2005, 16(10): …